-
-loop drug discovery. The project aims to establish an integrated Design–Make–Test–Analyze (DMTA) platform combining generative AI, ultra-large synthetically accessible chemical spaces, physics-informed
-
immune-cell phenotyping a strong record of experimental research, ideally including a high-quality first-author publication the ability to design, execute, and interpret mechanistic experiments
-
Basel (IOB) is a pioneering research institute that integrates basic and clinical ophthalmology research. Its mission is to drive innovation in understanding vision and associated diseases, as
-
generation of the electroretinogram and how approaches using multielectrode recordings and novel light stimulus designs could improve the signal-to-noise ratio.
-
of health and disease. We are home to more than 67 research groups and over 800 employees across six locations in the heart of Basel. Our collaborative and international environment fosters innovation